Study Links Autism Genes to Shared Pathway
Researchers at Boston Children's Hospital identify the ZFX gene as a possible factor in autism's higher prevalence in males.
Updated on Nov. 4, 2026 in Autism
Live Poll
Do you think now is a good time to expect better autism treatments?
Boston Children's Hospital researchers published findings in Nature identifying transcriptomic convergence among autism-linked genes and highlighting the ZFX gene. The study found that disrupting one autism-linked gene can down-regulate many others.
Why it matters
The findings may help explain why autism is four to five times more common in males than females. They also suggest therapies that upregulate many autism-associated genes could be possible to develop.
In a human cell model, down-regulating one autism-linked gene reduced expression of many other autism-linked genes, and more than sixty X chromosome genes escape inactivation. Whether these cell-level patterns translate to clinical outcomes remains unestablished.
The players
Boston Children's Hospital
A major pediatric teaching hospital affiliated with Harvard Medical School, based in Boston, Massachusetts.
Nature
A leading international scientific journal that publishes peer-reviewed research across the natural sciences and medicine.
The details
Researchers studied a number of autism-linked genes in a human cell model and observed similar genetic patterns regardless of which gene was disrupted. The team proposed that higher ZFX expression in females, which results from its expression on both X chromosomes, could drive protection against mutations in autism-related genes.
Timeline
November 4, 2026: Nature publishes the transcriptomic convergence and ZFX findings.
Health Landscape
The findings build on decades of research into X chromosome inactivation, the process that silences one X chromosome in female cells. By identifying ZFX as a gene that escapes this silencing, the study adds a specific candidate to explanations of the sex gap in autism prevalence.
The study does not yet offer a treatment for people with autism. Its suggestion that therapies targeting ZFX or other autism-associated genes may be developed points to a research direction rather than an available option for patients.
The takeaway
Autism's higher prevalence in males may relate in part to how X-linked genes like ZFX are expressed in females. Further research will be needed before any clinical application is established.
Further reading
For related coverage of research into the condition, see our Autism section.
More information
Read the full Nature journal article on transcriptomic convergence in autism for the study's methods and findings.
Source note: This article includes information reported by News-Medical.
Live Poll
Do you think now is a good time to expect better autism treatments?
